# Resource Support Program for AIDS Vaccine Development

Canonical: https://abierto.us/opportunities/75n93025c00011

- Solicitation number: 75N93025C00011
- Notice type: Award notice
- Status: Awarded to Quality Biological Inc. for $25,374,525.00
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Niaid (75N930)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AN12 Health R&D Services; Health Care Services; Applied Research
- Set-aside: Total small business set-aside
- Place of performance: Gaithersburg, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Gaithersburg. https://abierto.us/cities/gaithersburg-md-2431175
- First posted: April 9, 2025
- Last posted: April 9, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/c95fc94570d443998b01795b2d9b74dd/view

## Description

The discovery and development of an Acquired Immune Deficiency Syndrome (AIDS) vaccine remains among the highest research priorities of the National Institute of Allergy and Infectious Diseases (NIAID) and is a principal mission of NIAID’s Division of AIDS (DAIDS).

To support this mission, NIAID has provided high-quality, novel, and targeted reagents, assays and services for investigators engaged in AIDS vaccine-related research, including NIAID funded grantees and contractors, other NIH-funded researchers, and investigators supported through various Non-Governmental Organizations (NGOs). Supported contractors include the DAIDS Simian Vaccine Evaluation Units (SVEUs) and their support contractors.

These services are provided through this contract by investigator request to NIAID and NIAID staff approval. The incumbent contractor is Quality Biological, Inc.(HHSN272201800007C).

Services provided under the current contract have included providing overlapping peptide sets for Simian Immuno-deficiency Virus/Simian Human Immuno-deficiency Virus (SIV/SHIV) and Human Immuno-deficiency Virus (HIV), polyclonal and monoclonal antibodies, SIV and SHIV challenge stocks, and storage and shipping of kits for proficiency testing/standardization for neutralization assays (TZM-bl neutralization assay).

The Resource Support Program for AIDS Vaccine Development contract complements the “NIH HIV Reagent Program” (www.hivreagentprogram.org/) which supplies a larger variety of reagents to both vaccine and non-vaccine AIDS researchers as well.

## Award on USAspending

- Recipient: Quality Biological Inc. (UEI V7ACWSNAL845)
- Contract: 75N93025C00011, definitive contract
- Obligated: $4,780,359.00
- Competition: Full and Open Competition After Exclusion of Sources, 1 offers received
- Link: award number 75N93025C00011 equals the contract number; same awarding office 75N930 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75N93025C00011_7529_-NONE-_-NONE-/


## Publications

- April 9, 2025: Award notice. Notice c95fc94570d443998b01795b2d9b74dd. https://sam.gov/workspace/contract/opp/c95fc94570d443998b01795b2d9b74dd/view

## Points of contact

- Evguenia Mathur, jane.mathur@nih.gov, 3014510237
- Ashley Kinderdine, ashley.kinderdine@nih.gov, 2406695154

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n93025c00011.